Anti-Siglec-2/CD22 Antibody (Pinatuzumab)
Catalog No.
F1197
Anti-Siglec-2/CD22 Antibody (Pinatuzumab)
Featured Products
Pinatuzumab (Anti-Siglec-2 / CD22) is a humanized IgG1 monoclonal antibody targeting CD22. It has potential anti-tumor activity and can be used in the study of non-Hodgkin's lymphoma. Molecular weight: 146.64 KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.64 kDa
Dry ice
1639820-81-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Pinatuzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P20273
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD22 His at 2 ug/mL can bind Anti-Siglec-2/CD22 Antibody (Pinatuzumab)
Siglec-2 / CD22
Please avoid freeze-thaw cycles.